A detailed history of Pathstone Holdings, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 7,117 shares of SRPT stock, worth $800,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,117
Previous 7,277 2.2%
Holding current value
$800,520
Previous $1.15 Million 22.72%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$124.33 - $156.75 $19,892 - $25,080
-160 Reduced 2.2%
7,117 $888,000
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $25,612 - $37,030
226 Added 3.21%
7,277 $1.15 Million
Q1 2024

May 13, 2024

BUY
$93.7 - $141.53 $228,721 - $345,474
2,441 Added 52.95%
7,051 $912,000
Q4 2023

Feb 14, 2024

BUY
$67.31 - $124.76 $310,299 - $575,143
4,610 New
4,610 $444,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.85B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.